title: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.
abstract: BACKGROUND
  The cholecalciferol inputs required to achieve or maintain any given serum 25-hydroxycholecalciferol concentration are not known, particularly within ranges comparable to the probable physiologic supply of the vitamin.
  
  
  OBJECTIVE
  The objectives were to establish the quantitative relation between steady state cholecalciferol input and the resulting serum 25-hydroxycholecalciferol concentration and to estimate the proportion of the daily requirement during winter that is met by cholecalciferol reserves in body tissue stores.
  
  
  METHODS
  Cholecalciferol was administered daily in controlled oral doses labeled at 0, 25, 125, and 250 micro g cholecalciferol for approximately 20 wk during the winter to 67 men living in Omaha (41.2 degrees N latitude). The time course of serum 25-hydroxycholecalciferol concentration was measured at intervals over the course of treatment.
  
  
  RESULTS
  From a mean baseline value of 70.3 nmol/L, equilibrium concentrations of serum 25-hydroxycholecalciferol changed during the winter months in direct proportion to the dose, with a slope of approximately 0.70 nmol/L for each additional 1 micro g cholecalciferol input. The calculated oral input required to sustain the serum 25-hydroxycholecalciferol concentration present before the study (ie, in the autumn) was 12.5 micro g (500 IU)/d, whereas the total amount from all sources (supplement, food, tissue stores) needed to sustain the starting 25-hydroxycholecalciferol concentration was estimated at approximately 96 micro g (approximately 3800 IU)/d. By difference, the tissue stores provided approximately 78-82 micro g/d.
  
  
  CONCLUSIONS
  Healthy men seem to use 3000-5000 IU cholecalciferol/d, apparently meeting > 80% of their winter cholecalciferol need with cutaneously synthesized accumulations from solar sources during the preceding summer months. Current recommended vitamin D inputs are inadequate to maintain serum 25-hydroxycholecalciferol concentration in the absence of substantial cutaneous production of vitamin D.
authors.affiliation: Creighton University, Omaha, NE 68131, USA. rheaney@creighton.edu
authors.forename: Robert P
authors.initials: RP
authors.lastname: Heaney
authors.forename: K Michael
authors.initials: KM
authors.lastname: Davies
authors.forename: Tai C
authors.initials: TC
authors.lastname: Chen
authors.forename: Michael F
authors.initials: MF
authors.lastname: Holick
authors.forename: M Janet
authors.initials: MJ
authors.lastname: Barger-Lux
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002112:Calcifediol / Q000097:blood*; D002118:Calcium / Q000097:blood; D002762:Cholecalciferol / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D009329:Nebraska; D012621:Seasons
chemical_list: D002762:Cholecalciferol; D002112:Calcifediol; D002118:Calcium